Insider Transactions in Q4 2025 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2025
|
Kathleen S. Capps Officer |
SELL
Open market or private sale
|
Direct |
323
-3.71%
|
$4,522
$14.23 P/Share
|
|
Dec 05
2025
|
Brendan Luu Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,394
-3.51%
|
$19,516
$14.23 P/Share
|
|
Dec 05
2025
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
798
-3.53%
|
$11,172
$14.23 P/Share
|
|
Dec 05
2025
|
Harry R. Trout Iii Officer |
SELL
Open market or private sale
|
Direct |
542
-3.21%
|
$7,588
$14.23 P/Share
|
|
Dec 05
2025
|
Jay R. Luly President and CEO |
SELL
Open market or private sale
|
Direct |
4,743
-0.55%
|
$66,402
$14.23 P/Share
|
|
Dec 05
2025
|
Yat Sun Or Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,390
-0.64%
|
$33,460
$14.23 P/Share
|
|
Dec 05
2025
|
Tara Lynn Kieffer Chief Product Strategy Officer |
SELL
Open market or private sale
|
Direct |
2,106
-6.44%
|
$29,484
$14.23 P/Share
|
|
Dec 02
2025
|
Harry R. Trout Iii Officer |
SELL
Open market or private sale
|
Direct |
380
-2.2%
|
$4,940
$13.96 P/Share
|
|
Dec 02
2025
|
Kathleen S. Capps Officer |
SELL
Open market or private sale
|
Direct |
207
-2.32%
|
$2,691
$13.96 P/Share
|
|
Dec 01
2025
|
Harry R. Trout Iii Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
105
-0.6%
|
$1,470
$14.12 P/Share
|
|
Dec 01
2025
|
Kathleen S. Capps Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-0.95%
|
$1,190
$14.12 P/Share
|
|
Dec 01
2025
|
Brendan Luu Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
498
-1.24%
|
$6,972
$14.12 P/Share
|
|
Dec 01
2025
|
Yat Sun Or Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
753
-0.2%
|
$10,542
$14.12 P/Share
|
|
Dec 01
2025
|
Tara Lynn Kieffer Chief Product Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
753
-2.25%
|
$10,542
$14.12 P/Share
|
|
Dec 01
2025
|
Jay R. Luly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,885
-0.22%
|
$26,390
$14.12 P/Share
|
|
Nov 25
2025
|
Kathleen S. Capps Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,163
+26.02%
|
-
|
|
Nov 25
2025
|
Harry R. Trout Iii Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,463
+27.11%
|
-
|